Slingshot Biosciences Funding: $49M Raised, Series A (2023)
Slingshot Biosciences is a Biotech company. It has raised $49M in total funding. Latest round: Series A.
Slingshot Biosciences funding overview
Slingshot Biosciences is a Biotech company. Slingshot Biosciences has raised $49M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2023. The round record for Slingshot Biosciences runs through 2023; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Northpond Ventures, Anterra Capital. 3 distinct backers are named across the disclosed rounds.
Slingshot Biosciences at a glance
Total raised
$49M
Latest round
Series A
Latest round date
February 2023
Industry
Biotech
Notable investors
ARCH Venture Partners, Northpond Ventures, Anterra Capital
Frequently asked about Slingshot Biosciences funding
How much has Slingshot Biosciences raised?
Slingshot Biosciences has raised $49M in total disclosed funding across the rounds on record.
Who has invested in Slingshot Biosciences?
ARCH Venture Partners, Northpond Ventures, Anterra Capital are named among the investors backing Slingshot Biosciences.
What was the latest Slingshot Biosciences funding round?
The most recent disclosed round is a Series A, announced in February 2023.
Where is Slingshot Biosciences based?
No headquarters location is disclosed for Slingshot Biosciences.
What sector does Slingshot Biosciences operate in?
Slingshot Biosciences is tracked under Biotech, with $49M in disclosed funding.
When did Slingshot Biosciences last raise?
The last disclosed Slingshot Biosciences round closed in February 2023 at Series A.
Every Slingshot Biosciences figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies at a similar stage.
